Back to Search
DR. HARRY D. BEAR M.D.
M.D.
Surgery Physician
NPI: 1508950825IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
0101027958(VA)
Education
OTHER
Class of 1975
Research & Publications (20)
Walter Lawrence, Jr.: a tribute to a surgical oncologist. "Been there, done that".
PMID 15895456·J Surg Oncol·2005
8-other
The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.
PMID 14559892·J Clin Oncol·2003
3-trial
Adoptive immunotherapy of cancer with pharmacologically activated lymph node lymphocytes: a pilot clinical trial.
PMID 11499810·Cancer Immunol Immunother·2001
3-trial
Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27.
PMID 16606972·J Clin Oncol·2006
2-rct
Effects of surgical excision on survival of patients with stage IV breast cancer.
PMID 19375721·J Surg Res·2010
4-observational
Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2.
PMID 19198835·Cancer Immunol Immunother·2009
7-preclinical
Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice.
PMID 19336265·Int Immunopharmacol·2009
7-preclinical
Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis.
PMID 18425677·Breast Cancer Res Treat·2009
7-preclinical
Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells.
PMID 18979098·Cancer Immunol Immunother·2009
7-preclinical
Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors.
PMID 18381452·Cancer Res·2008
7-preclinical
Completion axillary lymph node dissection for breast cancer: immediate versus delayed versus none.
PMID 18640928·J Clin Oncol·2008
8-other
Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.
PMID 18258986·J Clin Oncol·2008
4-observational
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
PMID 18258988·J Clin Oncol·2008
6-review
Measuring circulating tumor cells as a surrogate end point for adjuvant therapy of breast cancer: what do they mean and what should we do about them?
PMID 18323543·J Clin Oncol·2008
8-other
Reaping the harvest from neoadjuvant therapy for breast cancer: reducing morbidity with sentinel lymph node biopsy.
PMID 17192916·J Surg Oncol·2007
8-other
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.
PMID 17998286·Ann Oncol·2007
6-review
Sentinel node micrometastases and non-sentinel nodes in breast cancer: how much do we need to know?
PMID 16567763·J Clin Oncol·2006
8-other
Tumor bed boost omission after negative re-excision in breast-conservation treatment.
PMID 16614879·Ann Surg Oncol·2006
8-other
Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.
PMID 15837984·J Clin Oncol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1250 E MARSHALL ST, SURGERY
RICHMOND, VA 23298 - Phone
- (804) 828-9325
Quick Facts
- NPI
- 1508950825
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 51
- Publications
- 20
Are you this provider?
Claim Your Profile